Titlebook: Emerging Technologies for Diagnosing Alzheimer‘s Disease; Innovating with Care Marianne Boenink,Harro van Lente,Ellen Moors Book 2016 The E

處理

endure

Informally Regulated Innovation Systems: Challenges for Responsible Innovation in Diagnosticsto produce diagnostic innovations of questionable value. Wider patient and public engagement, together with robust, legitimate, and accountable regulatory regimes will be required to truly ‘innovate with care’.

confide

共同給與

2946-3386 isciplinary reflections on the social and ethical issues raised by promises of early diagnostics and asks under which conditions emerging diagnostic technologies can be considered a responsible innovation.?.The initial chapters in this edited volume provide an overview and a critical discussion of r

蒙太奇

Health, Technology and Societyhttp://image.papertrans.cn/e/image/308412.jpg

發(fā)生

https://doi.org/10.1057/978-1-137-54097-3Medical Sociology; Health; Technology; Diagnosis; diagnostics; responsible innovation; biomarkers; technolo

使長(zhǎng)胖

The Editor(s) (if applicable) and The Author(s) 2016

MOT

Emerging Technologies for Diagnosing Alzheimer‘s Disease978-1-137-54097-3Series ISSN 2946-3386 Series E-ISSN 2946-3378

jettison

The Case Studies of Senior Appointmentsb. The types of diagnostic tests recommended range from MRI and PET scans of the brain, to spinal taps, blood tests, simple eye cell tests, and even smelling peanut butter. Most of these tests measure so-called ‘biomarkers’: certain molecules in the body that are linked with the pathology thought to

火車(chē)車(chē)輪